← Leaderboards
Burton Combes
University Of Texas Sw Med Ctr/Dallas
$4,623,448
Attributed
$4,623,448
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $40.7K · FY2005–06$50K$37.5K$25K$12.5K$0
'05
'06
Funding mix
By agency
NIH$4,623,448 · 4
By mechanism
R01$3,232,805 · 1
M01$1,390,643 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Sw Med Ctr/Dallas
Same institution · by research overlap
- Steven A Kliewer$8,041,313
- John M. Dietschy$10,939,034
- Marlyn J Mayo$1,716,530
- Joseph L Goldstein$29,369,162
- David W. Russell$22,966,286
Others in their field
Top investigators on “Primary Biliary Cirrhosis”
- Merrill E Gershwin · University Of California At Davis$23,357,355
- Konstantinos N Lazaridis · Mayo Clinic Rochester$6,329,413
- Gianfranco D. Alpini · Texas A&M University Health Science Ctr$5,765,914
- Michael H Nathanson · Yale University$5,063,077
- Shannon Stroud Glaser · Texas A&M University Health Science Ctr$4,370,622
- Siegfried M Musser · Texas A&M University Health Science Ctr$4,001,025
Research focus
Primary Biliary CirrhosisHuman SubjectClinical ResearchHuman Therapy EvaluationUrsodeoxycholateCombination ChemotherapyBilirubinMethotrexateImmunoglobulin MPruritisAscitesEsophageal VaricesHistologyPlacebosBiliary Tract Disorder ChemotherapyLiver Disorder ChemotherapyAlbuminsAlkaline PhosphataseAspartate TransaminaseClinical TrialsEdemaFatigueHepatic Coma /EncephalopathyLiver Transplantation
Grant awards (15)
URSODEOXYCHOLIC ACID (UDCA) IN PRIMARY BILIARY CIRRHOSIS$2,657
M01 · FY2006 · RR · contact PI
UDCA &METHOTREXATE FOR PRIMARY BILIARY CIRRHOSIS$36,804
M01 · FY2005 · RR
URSODEOXYCHOLIC ACID (UDCA) IN PRIMARY BILIARY CIRRHOSIS$3,893
M01 · FY2005 · RR
UDCA &Methotrexate for Primary Biliary Cirrhosis$55,592
M01 · FY2004 · RR
Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis$6,201
M01 · FY2004 · RR
URSODIOL-METHOTREXATE FOR PRIMARY BILIARY CIRRHOSIS$819,876
R01 · FY2003 · DK
URSODIOL-METHOTREXATE FOR PRIMARY BILIARY CIRRHOSIS$811,957
R01 · FY2002 · DK
UDCA AND METHOTREXATE FOR PRIMARY BILIARY CIRRHOSIS$321,374
M01 · FY2002 · RR
URSODEOXYCHOLIC ACID IN PRIMARY BILIARY CIRRHOSIS$321,374
M01 · FY2002 · RR
URSODIOL-METHOTREXATE FOR PRIMARY BILIARY CIRRHOSIS$804,267
R01 · FY2001 · DK
UDCA AND METHOTREXATE FOR PRIMARY BILIARY CIRRHOSIS$321,374
M01 · FY2001 · RR
URSODEOXYCHOLIC ACID IN PRIMARY BILIARY CIRRHOSIS$321,374
M01 · FY2001 · RR
URSODIOL-METHOTREXATE FOR PRIMARY BILIARY CIRRHOSIS$796,705
R01 · FY2000 · DK
URSODEOXYCHOLIC ACID IN PRIMARY BILIARY CIRRHOSIS$0
M01 · FY2000 · RR
UDCA AND METHOTREXATE FOR PRIMARY BILIARY CIRRHOSIS$0
M01 · FY2000 · RR